Trials / Completed
CompletedNCT03498417
Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Serum Antibodies Against the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Graves' Disease and Graves' Orbitopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- University of Pisa · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The study is aimed at assessing IGF-1R-Abs in patients with Graves' disease, with or without GO, compared with healthy subjects and patients with autoimmune thyroiditis in a cross-sectional investigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serum antibodies against the IGF-1R | Measurement of antibodies against the IGF-1R in serum samples by ELISA |
Timeline
- Start date
- 2018-06-20
- Primary completion
- 2018-07-20
- Completion
- 2018-07-20
- First posted
- 2018-04-13
- Last updated
- 2018-07-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03498417. Inclusion in this directory is not an endorsement.